Evidence map›Paper›PMID 30103253›Full record

ArticleThe European journal of neuroscience2018

Sex differences in the effect of cannabinoid type 1 receptor deletion on locus coeruleus-norepinephrine neurons and corticotropin releasing factor-mediated responses.

Ryan R Wyrofsky, Beverly A S Reyes, Daohai Yu, Lynn G Kirby, Elisabeth J Van Bockstaele

Abstract read
In one paragraph

Article in The European journal of neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Ryan R WyrofskyDepartment of Pharmacology and Physiology, College of Medicine, Drexel University, Philadelphia, Pennsylvania.ORCID 0000-0002-9557-0350
Beverly A S ReyesDepartment of Pharmacology and Physiology, College of Medicine, Drexel University, Philadelphia, Pennsylvania.
Daohai YuDepartment of Clinical Sciences, Temple Clinical Research Institute, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.
Lynn G KirbyDepartment of Anatomy and Cell Biology, Center for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.
Elisabeth J Van BockstaeleDepartment of Pharmacology and Physiology, College of Medicine, Drexel University, Philadelphia, Pennsylvania.
Drexel University · USClinical Research Institute · USTemple University · US

Funding

Pilot Projects Core (PPC)P30DA013429 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI SCOTT M. RAWLS · 2000 to 2026
$34.6M
Modulation of norepinephrine by cannabinoidsR01DA020129 · NIDA · THOMAS JEFFERSON UNIVERSITY · PI VAN BOCKSTAELE, ELISABETH J · 2005 to 2017
$3.5M
NIDA NIH HHS P30 DA013429NIDA NIH HHS R01 DA020129
6 · The paper itself

Abstract

Cannabinoids are capable of modulating mood, arousal, cognition and behavior, in part via their effects on the noradrenergic nucleus locus coeruleus (LC). Dysregulation of LC signaling and norepinephrine (NE) efflux in the medial prefrontal cortex (mPFC) can lead to the development of psychiatric disorders, and CB1r deletion results in alterations of α2- and β1-adrenoceptors in the mPFC, suggestive of increased LC activity. To determine how CB1r deletion alters LC signaling, whole-cell patch-clamp electrophysiology was conducted in LC-NE neurons of male and female wild type (WT) and CB1r-knock out (KO) mice. CB1r deletion caused a significant increase in LC-NE excitability and input resistance in male but not female mice when compared to WT. CB1r deletion also caused adaptations in several indices of noradrenergic function. CB1r/CB2r-KO male mice had a significant increase in cortical NE levels and tyrosine hydroxylase and CRF levels in the LC compared to WT males. CB1r/CB2r-KO female mice showed a significant increase in LC α2-AR levels compared to WT females. To further probe actions of the endocannabinoid system as an anti-stress neuromediator, the effect of CB1r deletion on CRF-induced responses in the LC was investigated. The increase in LC-NE excitability observed in male and female WT mice following CRF (300 nM) bath application was not observed in CB1r-KO mice. These results indicate that cellular adaptations following CB1r deletion cause a disruption in LC-NE signaling in males but not females, suggesting underlying sex differences in compensatory mechanisms in KO mice as well as basal endocannabinoid regulation of LC-NE activity.

Indexed as

AnimalsCannabinoidsCorticotropin-Releasing HormoneFemaleLocus CoeruleusMaleMice, KnockoutNeuronsNorepinephrinePrefrontal CortexReceptor, Cannabinoid, CB1Sex CharacteristicsTyrosine 3-MonooxygenaseCannabinoidsCorticotropin-Releasing HormoneNorepinephrineReceptor, Cannabinoid, CB1Tyrosine 3-Monooxygenasearousalpsychiatric disorderssex differencesstress

Identifiers

PMID30103253
PMCPMC6476636
OpenAlexW2887858669

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.